Table 5.
Compound | Toxicological Information |
---|---|
Diosgenin | Oral LD50 (rat) > 8 g/kg |
Intraperitoneal LD50 (rat) 4872 mg/kg | |
Oral LD50 (mouse) > 8 g/kg | |
Intraperitoneal LD50 (mouse) 3564 mg/kg | |
Dioscin | Subcutaneous LD50 (mouse) >300 mg/kg |
Oral TDLo (rat) 1050 mg/kg/1W (intermittent) | |
Oral TDLo (mouse):400 mg/kg/10D (intermittent) | |
Tigogenin | Intraperitoneal LDLo (rat):10 mg/kg |
Harmine | Intramuscular TDLo (man):3 mg/kg |
Intravenous LDLo (cat) 10 mg/kg | |
Subcutaneous LDLo (frog) 300 mg/kg | |
Subcutaneous LD50 (mouse) 243 mg/kg | |
Intravenous LDLo (mouse) 50 mg/kg | |
Subcutaneous LD50 (rat) 200 mg/kg | |
Harmane | Intraperitoneal LD50 (mouse) 50 mg/kg |
Interperitoneal TDLo (rat) 1 mg/kg | |
Intraperitoneal LD50 (rabbit) 200 mg/kg | |
Harmaline | Subcutaneous LD50 (rat) 120 mg/kg |
Subcutaneous LD50 (mouse) 120 mg/kg | |
Intraperitoneal TDLo (rat) 4 mg/kg | |
Norharmane | Oral TDLo (rat) 1050 mg/kg/6W (continuous) |
LD50, median lethal dose; TDLo, lowest published toxic dose; LDLo, lowest lethal dose.